News

Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable. This new drug promises better adherence and wider access, especially in ...
Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...
The FDA's approval of lenacapavir, a highly effective HIV prevention drug, sparks debate in India due to its high cost of ₹24 ...
HIV targets the white blood cells and weakens the immune system. This would make the person prone to diseases like ...
The US FDA has approved lenacapavir, the first twice-yearly injection for HIV prevention, which provides near-complete ...
The White House budget proposal would roll back next year's federal HIV prevention funding to levels not seen since around ...
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...